TNGX

Tango Therapeutics Inc. (TNGX)

Stock · NASDAQ · Health Care

$23.34as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$19.52
Industry
Biotechnology: Pharmaceutical Preparations

Tango Therapeutics Inc. Competitors

Chosen by industry and closest market cap.

  • TNGX
    Tango Therapeutics Inc.
    $23.34
    ▼ 7.67%
    Market cap $3.94BP/E
  • VKTX
    Viking Therapeutics Inc. Common Stock
    $32.15
    ▼ 5.05%
    Market cap $3.80BP/E
    $22.96$43.15
  • MANE
    Veradermics Incorporated Common Stock
    $97.53
    ▼ 4.20%
    Market cap $4.26BP/E
    $32$131.24
  • ELVN
    Enliven Therapeutics Inc. Common Stock
    $57.82
    ▼ 4.43%
    Market cap $3.53BP/E
    $14.79$62.32
  • ACAD
    ACADIA Pharmaceuticals Inc. Common Stock
    $29.13
    ▼ 2.02%
    Market cap $4.39BP/E 12.85
    $19.69$30.96
  • GPCR
    Structure Therapeutics Inc. American Depositary Shares
    $47.38
    ▼ 3.74%
    Market cap $3.44BP/E
    $18.26$94.9
  • TLX
    Telix Pharmaceuticals Limited American Depositary Shares
    $11.28
    ▼ 0.84%
    Market cap $3.39BP/E
    $6.28$12.5

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
178.71M
Total value held
$3.69B
Institutional holders
189
Top holders this quarter
  • Unknown13.30M
  • Unknown12.81M
  • Unknown10.88M
  • Unknown10.53M
  • Unknown9.91M
  • Unknown9.10M
  • Unknown8.75M
  • Unknown8.00M
  • Unknown7.27M
  • Unknown6.37M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.